InvestorsHub Logo

Bubae

08/23/22 2:37 PM

#43868 RE: HighYieldStocks #43867

Need a little perspective from the filing to call that $400K+ EBITDA number into question. $14,000 segmented net earnings for ARIA in Q1 and $2600 net for the first 6 months of 2022. Looks like we lost a bit there in contrast to a Q2 EBITDA of $400K+ statement. Also, No mention that Q2 press that this is the first filing that depicts that they now have notes "in default". There is a reason this company always talks about EBITDA in their press releases instead of debt and real earnings.


Ethema Reports Second Quarter Results
August 15, 2022 15:00 ET | Source: Ethema Health Corporation
https://www.globenewswire.com/en/news-release/2022/08/15/2498474/0/en/Ethema-Reports-Second-Quarter-Results.html

the second quarter 2022 10-Q. The Company’s ARIA subsidiary continued its growth and had a $404,700.00 EBITDA for the second quarter which was a 117% increase over the first quarter of 2022.


For the quarterly period ended June 30, 2022
https://sec.report/Document/0001903596-22-000529/



For the quarterly period ended March 31, 2022
https://sec.report/Document/0001903596-22-000301/